These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9728551)

  • 41. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
    Kouchi I; Yasuoka S; Ueda Y; Ogura T
    Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women.
    Shimoya K; Zhang Q; Temma K; Kimura T; Tsujie T; Tsutsui T; Wasada K; Kanzaki T; Koyama M; Murata Y
    Maturitas; 2006 May; 54(2):141-8. PubMed ID: 16289563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis.
    Shimoya K; Moriyama A; Ogata I; Nobunaga T; Koyama M; Azuma C; Murata Y
    Mol Hum Reprod; 2000 Sep; 6(9):829-34. PubMed ID: 10956555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells.
    Sommer U; Costello CE; Hayes GR; Beach DH; Gilbert RO; Lucas JJ; Singh BN
    J Biol Chem; 2005 Jun; 280(25):23853-60. PubMed ID: 15843376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.
    Ding A; Thieblemont N; Zhu J; Jin F; Zhang J; Wright S
    Infect Immun; 1999 Sep; 67(9):4485-9. PubMed ID: 10456890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury.
    Wang X; Li X; Xu L; Zhan Y; Yaish-Ohad S; Erhardt JA; Barone FC; Feuerstein GZ
    Mol Pharmacol; 2003 Oct; 64(4):833-40. PubMed ID: 14500739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretory leukocyte protease inhibitor in the cervical mucus and in the fetal membranes.
    Helmig R; Uldbjerg N; Ohlsson K
    Eur J Obstet Gynecol Reprod Biol; 1995 Mar; 59(1):95-101. PubMed ID: 7781866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgE-mediated histamine release from nasal mucosa is inhibited by SLPI (secretory leukocyte protease inhibitor) to the level of spontaneous release.
    Westin U; Lundberg E; Ohlsson K
    Mediators Inflamm; 1998; 7(3):217-20. PubMed ID: 9705610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trichomonas vaginalis surface proteinase activity is necessary for parasite adherence to epithelial cells.
    Arroyo R; Alderete JF
    Infect Immun; 1989 Oct; 57(10):2991-7. PubMed ID: 2789190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
    Janciauskiene S; Brandt L; Wallmark A; Westin U; Krakau T
    Exp Eye Res; 2006 Mar; 82(3):505-11. PubMed ID: 16202405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
    Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
    J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats.
    Gast A; Anderson W; Probst A; Nick H; Thompson RC; Eisenberg SP; Schnebli H
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):889-94. PubMed ID: 2327652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission.
    Pillay K; Coutsoudis A; Agadzi-Naqvi AK; Kuhn L; Coovadia HM; Janoff EN
    J Infect Dis; 2001 Feb; 183(4):653-6. PubMed ID: 11170993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective oxidation of methionyl residues in the human recombinant secretory leukocyte proteinase inhibitor. Effect on the inhibitor binding properties.
    Tomova S; Cutruzzolà F; Barra D; Amiconi G; Ascenzi P; Djinović Carugo K; Menegatti E; Sarti P; Schnebli HP; Bolognesi M
    J Mol Recognit; 1994 Mar; 7(1):31-7. PubMed ID: 7986566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of menstrual status on antibacterial activity and secretory leukocyte protease inhibitor production by human uterine epithelial cells in culture.
    Fahey JV; Wira CR
    J Infect Dis; 2002 Jun; 185(11):1606-13. PubMed ID: 12023766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function.
    Yang J; Zhu J; Sun D; Ding A
    Biochim Biophys Acta; 2005 Sep; 1745(3):310-7. PubMed ID: 16112212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
    Sallenave JM; Donnelly SC; Grant IS; Robertson C; Gauldie J; Haslett C
    Eur Respir J; 1999 May; 13(5):1029-36. PubMed ID: 10414400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.
    Shugars DC; Sauls DL; Weinberg JB
    Oral Dis; 1997 May; 3 Suppl 1():S70-2. PubMed ID: 9456661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel cysteine proteinase (CP65) of Trichomonas vaginalis involved in cytotoxicity.
    Alvarez-Sánchez ME; Avila-González L; Becerril-García C; Fattel-Facenda LV; Ortega-López J; Arroyo R
    Microb Pathog; 2000 Apr; 28(4):193-202. PubMed ID: 10764610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.
    Zhang Y; DeWitt DL; McNeely TB; Wahl SM; Wahl LM
    J Clin Invest; 1997 Mar; 99(5):894-900. PubMed ID: 9062347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.